In vitro study shows mouthwash component has antiviral effect against SARS-CoV2. However that is a long way away from any clinical use if ever.

Dr. Barry Dworkin

Medical Mythbusting Commentary for October 7, 2022

In vitro study shows mouthwash component has antiviral effect against SARS-CoV2. However that is a long way away from any clinical use if ever. Play Now | Play in Popup | Download

Source:
Mouthwashes may suppress SARS-CoV-2

Reference:
Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2

Related posts:

  1. Interesting laboratory study on how blood type A antigens on respiratory cells’ surface may provide another way for SARS-CoV-2 to enter the body increasing infection risk. However, no clinical outcome data as this looked only at in vitro effects.
  2. Heparin seems to reduce progression of COVID-19 in hospitalized people with moderate symptoms but not for the critically ill. Study author states that more research required to find the therapeutic “sweet spot”.
  3. Small in vitro study suggests two new COVID subvariants may dodge natural immunity response. However whether this translates into worsening clinical outcomes remains unanswered.
  4. A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
Bitnami